NRAS and cutaneous melanoma: Biologically, these tumors exhibit low mutational burden with scarce BRAF (3–11%) mutations but more frequent KIT (22%) and NRAS (5–14%) aberrations, contrasting with the UV-driven mutation profiles seen in cutaneous melanoma [8,9].